LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ:CYTR) today announced that President and CEO Steven A. Kriegsman and Tod Woolf, Ph.D., CEO of CytRx’s majority-owned subsidiary RXi Pharmaceuticals Corporation (RXi) are scheduled to present at the UBS Global Generic and Specialty Pharmaceuticals Conference on Tuesday, May 8 at 1:30 p.m. Eastern time (10:30 a.m. Pacific Time). The conference is being held at the Grand Hyatt New York in New York City.
